Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

November’s top stories: GSK’s Ebola vaccine, heroin offered outside trial

GlaxoSmithKline (GSK) reported positive results from an Ebola vaccine Phase I trial, AstraZeneca and Amgen announced data from the multi-arm Phase III AMAGINE-2 trial of brodalumab in plaque psoriasis and prescription heroin is offered in Vancouver to a few severely addicted individuals. Drugdevelopment-technology.com wraps-up key headlines from November.

Go Top